Tag - pharmaceuticals

 
 

PHARMACEUTICALS

JAPAN / Science & Health
Feb 22, 2020
Japan might approve anti-flu drug Avigan to treat coronavirus patients
Japan is considering using Avigan, an influenza medication developed by a unit of Fujifilm Holdings Corp., to treat patients of the novel coronavirus, health minister Katsunobu Kato says.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
WORLD / Science & Health
Feb 19, 2020
In fighting outbreaks like COVID-19, Big Pharma struggles to get out front
Sanofi has joined the race to combat coronavirus as the outbreak is kindling fears of a pandemic. The question is whether its effort will prove more effective than some of Big Pharma's past attempts to tackle dangerous new pathogens.
Japan Times
ASIA PACIFIC / Science & Health
Feb 18, 2020
Lung biopsy of deceased China patient shows SARS-like damage
Doctors studying a 50-year-old man who died in China last month from the new coronavirus found that the disease caused lung damage reminiscent of two prior coronavirus-related outbreaks, SARS and MERS.
Japan Times
ASIA PACIFIC / Science & Health
Feb 14, 2020
Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found.
Japan Times
ASIA PACIFIC / Science & Health
Feb 13, 2020
Results from Chinese drug trials for coronavirus due in weeks: expert
Chinese scientists are testing two antiviral drugs against the new coronavirus and preliminary clinical trial results are weeks away, the co-chair of a World Health Organization (WHO) meeting said on Wednesday.
Japan Times
ASIA PACIFIC / Science & Health
Feb 6, 2020
Drugmakers see long road ahead in coronavirus vaccine race
Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus cautioned that they have a long way to go.
Japan Times
BUSINESS
Jul 12, 2019
White House scraps key plan to lower U.S. drug prices, may target makers
The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drug makers.
Japan Times
WORLD / Science & Health
Jun 20, 2019
Eroding trust in vaccines leaves populations vulnerable, global study finds
Trust in vaccines — one of the world's most effective and widely-used medical products — is highest in poorer countries but weaker in wealthier ones where skepticism has allowed outbreaks of diseases such as measles to persist, a global study released Wednesday has found.
WORLD / Science & Health
May 16, 2019
Scientists launch push to beat cancer's ability to adapt against treatments
Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
Japan Times
BUSINESS / Companies
Mar 29, 2019
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment
Britain's AstraZeneca's biggest deal in recent memory give it access to the Japanese drugmaker's promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.
BUSINESS
Jan 2, 2019
China's generic drug makers struggle to survive bulk-buy policy onslaught
Even after a plunge last month that wiped $46 billion off Chinese health-care stocks, domestic drug makers may be far from their floor as a Beijing-led policy shift gathers pace.
Japan Times
BUSINESS / Companies
Nov 12, 2018
Japan's Takeda to seek shareholder approval of Shire purchase plan Dec. 5
Takeda Pharmaceutical Co. said it will convene an extraordinary meeting of shareholders Dec. 5 to win approval for its plan to acquire Irish drugmaker Shire PLC that would make it a global top 10 company in the industry.
Japan Times
ASIA PACIFIC / Science & Health
Oct 18, 2018
A blue pill is stopping HIV, world-first study shows
An antiviral pill taken daily by thousands of men across Sydney and other parts of Australia led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.
BUSINESS
Jul 7, 2018
Alzheimer's research gets glimmer of hope, but not for first time
For the few drugmakers that haven't given up on the decadeslong, elusive quest for a cure of Alzheimer's disease, each piece of news is a small signpost along a possible path to success — and billions of dollars in potential sales.
WORLD / Science & Health
Dec 9, 2017
Pfizer's breast cancer drug found to be superior to chemotherapy in Phase III study
Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer drug went about three months longer before their disease worsened than those who received chemotherapy in a late-stage study, according to data released Friday.
Japan Times
LIFE / Language / NEWS IN NIHONGO
Nov 6, 2017
Seirogan's trumpet melody is now a registered trademark
A trumpet melody used in the commercial for Taiko Pharmaceutical's Seirogan was registered as a trademark at the end of September, the first solely musical trademark to be registered in Japan.
Japan Times
JAPAN / Science & Health
Oct 26, 2017
Finance Ministry proposes cuts in medical fees and reductions in cost of new drugs
The Finance Ministry on Wednesday proposed reducing the fees charged by medical institutions, to curb social security costs which have ballooned due to the country's rapidly aging population.
Japan Times
JAPAN / Science & Health / A MATTER OF HEALTH
Oct 11, 2017
Japan's health ministry enlists anime hero in battle against overuse of antibiotics
The health ministry has enlisted the help of Amuro, the protagonist of the popular anime series "Mobile Suit Gundam," in its battle against the misuse and overuse of antibiotics — which can lead to antimicrobial resistance (AMR).
Japan Times
BUSINESS / Companies
Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'